Has Amanda Jurls received payments from drug or device companies?

Yes. Drug and device makers reported $6,666 in general payments to Amanda Jurls across 382 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amanda Jurls did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amanda Jurls come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amanda Jurls

Psychiatric/Mental Health · Nashville, TNNPI 1588092142

Payments from drug & device makers

$6,666in general payments, 2019–2025

Across 382 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$1K
Alkermes, Inc.$1K
Neurocrine Biosciences, Inc.$808
Teva Pharmaceuticals USA, Inc.$637
Johnson & Johnson$582
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$576
plus $2K from 15 others

What the payments were for

Food & beverage$6,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	114	$1,286
Alkermes, Inc.	44	$1,035
Neurocrine Biosciences, Inc.	43	$808
Teva Pharmaceuticals USA, Inc.	45	$637
Johnson & Johnson	34	$582
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	16	$576
AbbVie	15	$297
Otsuka America Pharmaceutical, Inc.	14	$283
E.r. Squibb & Sons, L.L.C.	10	$215
Axsome Therapeutics, Inc.	5	$182
Sunovion Pharmaceuticals Inc.	10	$149
Vanda Pharmaceuticals Inc.	5	$117
Ironshore Pharmaceuticals Inc.	6	$101
Tris Pharma Inc	6	$98
Indivior Inc.	4	$83
Corium, LLC	2	$55
Lundbeck LLC	3	$54
Noven Therapeutics, LLC	2	$45
Collegium Pharmaceutical, Inc.	2	$34
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Luye Pharma (USA) Ltd.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,666 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	11	$16,169
Aripiprazole	70	$2,808
Risperidone	27	$2,768
Guanfacine Hcl	16	$1,265
Divalproex Sodium	31	$1,180
Quetiapine Fumarate ErQuetiapine Fumarate	11	$1,000
Guanfacine Hcl ErGuanfacine Hcl	21	$957
Trazodone Hcl	52	$832
Fluoxetine Hcl	54	$552
Methylphenidate Hcl	12	$549
Escitalopram Oxalate	25	$516
Clonazepam	19	$464
Quetiapine Fumarate	20	$457
Duloxetine Hcl	33	$456
Mirtazapine	25	$425

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$297	$16,16911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Nashville

Kristian DambrinoNashville$449K
Lauren HansenNashville$263K
Aaron JonesNashville$20K
Kathleen McCoyNashville$12K
Preeti SrivastavaNashville$11K
Kersten WoodleeNashville$10K
Ariel NewtonNashville$10K
Robert McKeownNashville$10K
Debra YorkNashville$9K
Laura MelaroBolivar$682K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →